Propofol Impurity 17 | CAS 153752-00-2 - Request Quote
Propofol Impurity 17
| SZ CAT No: | SZ-P052041 |
| CAS No | 153752-00-2 |
| Mol.F. | C13H18O3 |
| Mol.Wt. | 222.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Propofol Impurity 17 is chemically Isopropyl 4-isopropoxybenzoate. Propofol Impurity 17 is supplied with detailed characterization data compliant with regulatory guideline. Propofol Impurity 17 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Propofol.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 153752-00-2
Purchase 153752-00-2
Order 153752-00-2
Enquire 153752-00-2
price of 153752-00-2
153752-00-2 Supplier
153752-00-2 Manufacturer
153752-00-2 Exporter
buy high quality Propofol Impurity 17
Purchase Propofol Impurity 17
Propofol Impurity 17 suppliers
Propofol Impurity 17 manufacturers
Propofol Impurity 17 price
Order Propofol Impurity 17
Enquire Propofol Impurity 17
Propofol Impurity 17 cost
Propofol Impurity 17 Supplier
Propofol Impurity 17 Distributor
Propofol Impurity 17 for Method Validation
Propofol Reference Standard
Propofol Impurity 17 for ANDA Filing
Propofol Impurity 17 for Forced Degradation Studies
Propofol Impurity 17 Identification Standards
Propofol Impurity 17 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


